Marex, the diversified global financial services platform, has appointed John Pietrowicz to its group board of directors. Pietrowicz, former CME Group CFO, brings a wealth of experience in financial markets and regulatory oversight to his new role.
According to a company release, Pietrowicz's expertise in corporate finance, accounting and M&A is valuable in navigating complex market dynamics and regulatory requirements.
Robert Pickering, Chairman of the Board of Directors of Marex, said: “(Pietrowicz) has a strong financial background, having served on FASAC; he has been one of the highest ranked CFOs by the investment community and is a experienced negotiator, which will be of enormous benefit to Marex.
As the former CFO of CME Group, Pietrowicz was instrumental in overseeing the financial strategy of derivatives exchanges globally. His responsibilities encompassed various functions, including corporate finance, accounting, investor relations and treasury management.
Prior to serving as CFO, Pietrowicz led corporate development and M&A initiatives within CME Group, enhancing his strategic acumen and deal-making prowess.
Key Expansion of Marex Leadership
Recently, Sarah Ing, non-executive director of Marex, was appointed non-executive director of City of London Investment Group PLC. This seasoned professional has over three decades of experience in accounting, investment banking and fund management.
Ing's appointment to the board of the City of London Investment Group marked a significant milestone in his illustrious career. She has experience in reputed organizations such as HSBC and UBS. Notably, she founded and successfully ran a hedge fund management business, Finance Magnates reported.
Last year, Marex Group plc. took an important step toward its proposed initial public offering of common stock by privately submitting a preliminary registration statement to the U.S. Securities and Exchange Commission. Although specific details regarding the offering size and price range remain undetermined, the Company plans to launch the public offering after completing the SEC review process, subject to market conditions and other factors.
Marex, the diversified global financial services platform, has appointed John Pietrowicz to its group board of directors. Pietrowicz, former CME Group CFO, brings a wealth of experience in financial markets and regulatory oversight to his new role.
According to a company release, Pietrowicz's expertise in corporate finance, accounting and M&A is valuable in navigating complex market dynamics and regulatory requirements.
Robert Pickering, Chairman of the Board of Directors of Marex, said: “(Pietrowicz) has a strong financial background, having served on FASAC; he has been one of the highest ranked CFOs by the investment community and is a experienced negotiator, which will be of enormous benefit to Marex.
As the former CFO of CME Group, Pietrowicz was instrumental in overseeing the financial strategy of derivatives exchanges globally. His responsibilities encompassed various functions, including corporate finance, accounting, investor relations and treasury management.
Prior to serving as CFO, Pietrowicz led corporate development and M&A initiatives within CME Group, enhancing his strategic acumen and deal-making prowess.
Key Expansion of Marex Leadership
Recently, Sarah Ing, non-executive director of Marex, was appointed non-executive director of City of London Investment Group PLC. This seasoned professional has over three decades of experience in accounting, investment banking and fund management.
Ing's appointment to the board of the City of London Investment Group marked a significant milestone in his illustrious career. She has experience in reputed organizations such as HSBC and UBS. Notably, she founded and successfully ran a hedge fund management business, Finance Magnates reported.
Last year, Marex Group plc. took an important step toward its proposed initial public offering of common stock by privately submitting a preliminary registration statement to the U.S. Securities and Exchange Commission. Although specific details regarding the offering size and price range remain undetermined, the Company plans to launch the public offering after completing the SEC review process, subject to market conditions and other factors.